Skip to main content
Clinical Trials/ACTRN12622001503718
ACTRN12622001503718Not yet recruiting未知

The efficacy of caffeine in restoring cognitive declines across 24 hours of sustained wakefulness in healthy adults

Australian Catholic University0 sites16 target enrollmentStarted: December 2, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
16

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 40 Years (—)
Sex
All

Inclusion Criteria

  • Healthy male and females aged between 18 and 40 years
  • No reported medical or sleep condition
  • Daily habitual caffeine consumption <300 mg

Exclusion Criteria

  • The use of cigarettes, drugs, or medications known to affect sleep in the three months prior to study admission.
  • Undertaken shift work or transmeridian travel in the month prior to study admission.

Investigators

Similar Trials

The efficacy of caffeine in restoring... | Clinical Trial